97 related articles for article (PubMed ID: 8558505)
1. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.
Tong W; Collantes ER; Chen Y; Welsh WJ
J Med Chem; 1996 Jan; 39(2):380-7. PubMed ID: 8558505
[TBL] [Abstract][Full Text] [Related]
2. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).
Araújo JQ; de Brito MA; Hoelz LV; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
Eur J Med Chem; 2011 Jan; 46(1):39-51. PubMed ID: 21074294
[TBL] [Abstract][Full Text] [Related]
3. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
Chaudhaery SS; Roy KK; Saxena AK
J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
[TBL] [Abstract][Full Text] [Related]
4. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
Shen LL; Liu GX; Tang Y
Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
[TBL] [Abstract][Full Text] [Related]
6. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis.
Roy KK; Dixit A; Saxena AK
J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
8. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
9. 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors.
Nazari M; Tabatabai SA; Rezaee E
Curr Comput Aided Drug Des; 2018; 14(4):391-397. PubMed ID: 30047333
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based 3D-QSAR studies of physostigmine analogues as acetylcholinesterase inhibitors.
Ul-Haq Z; Mahmood U; Jehangir B
Chem Biol Drug Des; 2009 Dec; 74(6):571-81. PubMed ID: 19843075
[TBL] [Abstract][Full Text] [Related]
11. Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors.
Więckowska A; Bajda M; Guzior N; Malawska B
Eur J Med Chem; 2010 Dec; 45(12):5602-11. PubMed ID: 20926161
[TBL] [Abstract][Full Text] [Related]
12. Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment.
Bernard P; Kireev DB; Chrétien JR; Fortier PL; Coppet L
J Comput Aided Mol Des; 1999 Jul; 13(4):355-71. PubMed ID: 10425601
[TBL] [Abstract][Full Text] [Related]
13. Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.
Cho SJ; Garsia ML; Bier J; Tropsha A
J Med Chem; 1996 Dec; 39(26):5064-71. PubMed ID: 8978837
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
[TBL] [Abstract][Full Text] [Related]
15. Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE.
Alonso D; Dorronsoro I; Rubio L; Muñoz P; García-Palomero E; Del Monte M; Bidon-Chanal A; Orozco M; Luque FJ; Castro A; Medina M; Martínez A
Bioorg Med Chem; 2005 Dec; 13(24):6588-97. PubMed ID: 16230018
[TBL] [Abstract][Full Text] [Related]
16. Validation of protein-based alignment in 3D quantitative structure-activity relationships with CoMFA models.
Golbraikh A; Bernard P; Chrétien JR
Eur J Med Chem; 2000 Jan; 35(1):123-36. PubMed ID: 10733609
[TBL] [Abstract][Full Text] [Related]
17. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
Yuan H; Kozikowski AP; Petukhov PA
J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
[TBL] [Abstract][Full Text] [Related]
18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
Kulkarni SS; Kulkarni VM
J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
[TBL] [Abstract][Full Text] [Related]
20. Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase.
Villalobos A; Blake JF; Biggers CK; Butler TW; Chapin DS; Chen YL; Ives JL; Jones SB; Liston DR; Nagel AA
J Med Chem; 1994 Aug; 37(17):2721-34. PubMed ID: 8064800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
